These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 12596078
1. Prognostic value of non-sustained ventricular tachycardias after acute myocardial infarction in the thrombolytic era: importance of combination with frequent ventricular premature beats. Drögemüller A, Seidl K, Schiele R, Schneider S, Gitt A, Gottwik M, von Leitner ER, Poppe C, Rettig-Stürmer G, Senges J, MITRA study Group. Z Kardiol; 2003 Feb; 92(2):164-72. PubMed ID: 12596078 [Abstract] [Full Text] [Related]
2. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction. Wienbergen H, Zeymer U, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Senges J, MITRA PLUS Study Group. Am J Cardiol; 2007 May 01; 99(9):1208-11. PubMed ID: 17478143 [Abstract] [Full Text] [Related]
3. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry). Koeth O, Zahn R, Gitt AK, Bauer T, Juenger C, Senges J, Zeymer U, Maximal Individual Therapy in Acute Myocardial Infarction Plus Study Group. Am J Cardiol; 2009 Oct 15; 104(8):1074-7. PubMed ID: 19801027 [Abstract] [Full Text] [Related]
12. Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studies. Frilling B, Schiele R, Gitt AK, Zahn R, Schneider S, Glunz HG, Gieseler U, Baumgärtel B, Asbeck F, Senges J, Maximum Individual Therapy in Acute Myocardial Infarction (MITRA), Myocardial Infarction Registry (MIR) Study Groups. Am Heart J; 2001 Feb 15; 141(2):200-5. PubMed ID: 11174332 [Abstract] [Full Text] [Related]
14. Small differences in non-fatal in-hospital reinfarctions complicating acute myocardial infarction as observed in current randomised controlled trials will not essentially influence long-term mortality. Results from the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry. Zahn R, Schiele R, Schneider S, Dönges K, Senges J. Z Kardiol; 2003 Oct 15; 92(10):847-51. PubMed ID: 14579049 [Abstract] [Full Text] [Related]
15. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. Gibson CM, Pride YB, Buros JL, Lord E, Shui A, Murphy SA, Pinto DS, Zimetbaum PJ, Sabatine MS, Cannon CP, Josephson ME, TIMI Study Group. J Am Coll Cardiol; 2008 Feb 05; 51(5):546-51. PubMed ID: 18237683 [Abstract] [Full Text] [Related]
19. Turbulence dynamics: an independent predictor of late mortality after acute myocardial infarction. Bauer A, Malik M, Barthel P, Schneider R, Watanabe MA, Camm AJ, Schömig A, Schmidt G. Int J Cardiol; 2006 Feb 08; 107(1):42-7. PubMed ID: 16337496 [Abstract] [Full Text] [Related]